Search research articles
Contact Us
Filters
Showing results (411-420 of 461) with videos related to
Page
of 47
Sort By:
Mayo Clinic Proceedings
|
September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal, Jason R Young, Matthew J Koster, et al.
Journal of Neurology
|
July 13, 2026
Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis
Tuba S Chaudhry, Nabeela Nathoo, Bianca Albites Coen, et al.
The Oncologist
|
May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
Gaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Molecular Cell
|
March 23, 2019
MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis
Pia-Amata Leimbacher, Samuel E Jones, Ann-Marie K Shorrocks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
Multiple Sclerosis and Related Disorders
|
August 30, 2024
Multiple sclerosis in Somali Americans: Nature or nurture?
Nabeela Nathoo, Nur Neyal, Elizabeth J Atkinson, et al.
Neurology. Genetics
|
September 11, 2025
Clinical Practice Guidelines for the Diagnosis, Management, and Surveillance of <i>LMNB1</i>-Related Autosomal Dominant Leukodystrophy
Radhika Dhamija, W Oliver Tobin, Pietro Cortelli, et al.
Journal of Medicinal Chemistry
|
December 29, 2010
Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2
John J Caldwell, Emma J Welsh, Cornelis Matijssen, et al.
Journal of the Neurological Sciences
|
January 13, 2026
The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination
Fiorella S Guido, John J Chen, Paul A Decker, et al.
The Biochemical Journal
|
April 22, 2016
Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2
Peter Hornyak, Trevor Askwith, Sarah Walker, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 461) with videos related to
Sort By:
Page
of 47
Mayo Clinic Proceedings
|
September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal, Jason R Young, Matthew J Koster, et al.
Journal of Neurology
|
July 13, 2026
Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis
Tuba S Chaudhry, Nabeela Nathoo, Bianca Albites Coen, et al.
The Oncologist
|
May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
Gaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Molecular Cell
|
March 23, 2019
MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis
Pia-Amata Leimbacher, Samuel E Jones, Ann-Marie K Shorrocks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
Multiple Sclerosis and Related Disorders
|
August 30, 2024
Multiple sclerosis in Somali Americans: Nature or nurture?
Nabeela Nathoo, Nur Neyal, Elizabeth J Atkinson, et al.
Neurology. Genetics
|
September 11, 2025
Clinical Practice Guidelines for the Diagnosis, Management, and Surveillance of <i>LMNB1</i>-Related Autosomal Dominant Leukodystrophy
Radhika Dhamija, W Oliver Tobin, Pietro Cortelli, et al.
Journal of Medicinal Chemistry
|
December 29, 2010
Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2
John J Caldwell, Emma J Welsh, Cornelis Matijssen, et al.
Journal of the Neurological Sciences
|
January 13, 2026
The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination
Fiorella S Guido, John J Chen, Paul A Decker, et al.
The Biochemical Journal
|
April 22, 2016
Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2
Peter Hornyak, Trevor Askwith, Sarah Walker, et al.
Page
of 47